Tag: Mpox

  • WHO considers emergency as mpox spreads to parts of Africa

    WHO considers emergency as mpox spreads to parts of Africa

    Two years after a global outbreak, fears are growing over a new strain of mpox — formerly known as monkeypox — identified in the Democratic Republic of Congo (DRC) and several neighboring countries. This deadlier and more transmissible strain, known as the Clade Ib subclade, has been spreading person-to-person in the DRC since September.

     

    The World Health Organization (WHO) announced on Sunday that it is considering convening an expert committee to decide whether to declare an international emergency, as it did during the global mpox outbreak in 2022.

     

    Unlike other strains where lesions and rashes are usually limited to the mouth, face, and genitals, the Clade Ib strain causes skin rashes across the entire body.

     

    The African Union health agency, Africa CDC, reported 14,479 confirmed and suspected cases of the strain and 455 deaths in the DRC as of August 3, with a mortality rate of around three percent.

     

    Authorities in four neighboring countries, including Burundi, which has reported 127 cases, have also confirmed mpox cases, although the specific strain has not been identified.

     

    The eight-member East African Community (EAC) has urged governments to educate their citizens on how to protect themselves and prevent the spread of the disease.

  • Mpox remains global health threat – WHO

    Mpox remains global health threat – WHO

    The World Health Organisation (WHO) says Monkeypox (Mpox) has remained a global health threat as 26 countries reported cases to WHO in July.

    The Director-General of the organisation,  Dr Tedros Ghebreyesus, said this on Thursday during an online media conference.

    Ghebreyesus said the outbreak in the Democratic Republic of the Congo showed no sign of slowing, with more than 11,000 cases reported in 2024 and 445 deaths, with children the most affected.

    He added that “South Africa recently reported 20 cases of mpox to WHO, including three deaths, with first cases in that country since 2022.

    “The cases were all men, and most self-identified as men who have sex with men.

    “None had reported any history of international travel, which suggests the confirmed cases are a small proportion of all cases, and that community transmission is ongoing.”

    According to him, WHO is supporting both DRC and South Africa to respond to the outbreaks, to conduct surveillance, to engage affected communities, and to develop immunisation strategies to ensure the most effective response.

    Ghebreyesus said that in early July,  United States reported a fourth human case of H5N1 following exposure to infected dairy cows.

    He said that Cambodia also reported two cases in children who had contact with sick or dead chickens.

    He added that “at the moment, no human-to-human transmission has been reported, which is why WHO continues to assess the risk to the general public as low.

    “However, our ability to assess and manage that risk is compromised by limited surveillance for influenza viruses in animals globally.

    “Understanding how these viruses are spreading and changing in animals is essential for identifying any changes that might increase the risk of outbreaks in humans, or the potential for a pandemic.”

    The WHO boss urged countries to strengthen influenza surveillance and reporting in animals and humans and share samples of influenza viruses with WHO collaborating centres.

    He also urged countries to share genetic sequences of human and animal flu viruses with publicly accessible databases and  provide protection for farm workers who may be exposed to infected animals

    “The countries should  accelerate research on avian influenza and encourage closer cooperation between animals and human health sectors,” he said.

    According to him, even as they continue to study the spread of H5N1, they also continue to study COVID-19, which still kills an average of 1700 people globally every week.

    He, however, noted that data has indicated that vaccine coverage has declined among health workers and people over 60, which are two of the most at-risk groups.

    Ghebreyesus said WHO has recommended people in the highest risk groups receive a COVID-19 vaccine within 12 months of last dose.

    Mpox is an infectious disease caused by the monkeypox virus, characterised by symptoms such as fever, headache,  swollen lymph nodes and chills.

    Other symptoms are exhaustion and rash that can look like pimples or blisters that appear on the face, inside the mouth and other parts of the body like the hands, feet, chest, genitals or anus.

    Mpox is a sexually transmitted disease transmitted through close contact with infected person.

  • Monkeypox no longer public health emergency

    Monkeypox no longer public health emergency

    The World Health Organisation (WHO) on Thursday declared that the multi-country outbreak of the mpox virus, which began around a year ago was no longer a public health emergency of international concern.

    WHO Director General, Tedros Ghebreyesus, said this while speaking to journalists in Geneva, a day after the emergency committee which made the emergency recommendation last July, advised the Director-General to declare it over.

    “However, as with COVID-19, that does not mean that the work is over. Mpox continues to pose significant public health challenges that need a robust, proactive and sustainable response,” Ghebreyesus said.

    He said there had been more than 87,000 cases, and 140 deaths worldwide reported to WHO, from 111 different countries.

    The virus, originally known as Monkey Pox, spreads through direct contact with bodily fluids and causes flu-like symptoms, and also pus-filled lesions on the skin.

    Last July, it was spreading rapidly, but he said WHO “has been very encouraged by the rapid response of countries. We now see steady progress in controlling the outbreak based on the lessons of HIV and working closely with the most affected communities.”

    Some 90 per cent fewer cases were reported in the past three months, compared with the previous three.

    From the beginning of the international outbreak of the disease, which has been in circulation since 1970, and occurred primarily in tropical rainforest areas of Central and West Africa, WHO stressed that most of those infected, recover without treatment in just a few weeks.

    He praised the work of community groups, and public health authorities.

    “For informing people of the risks of mpox, encouraging and supporting behaviour change, and advocating for access to tests, vaccines and treatments to be accessible to those in need.’’

    Cases of the virus were concentrated among men who have sex with men, especially those with multiple sexual partners.

    Ghebreyesus noted that while stigma has been a driving concern in managing the mpox epidemic, and continues to hamper access to care, “the feared backlash against the most affected communities has largely not materialised. For that, we are thankful.”

    He said inspite of the downward trend in cases, the virus was continuing to impact all regions, including Africa, where transmission “is still not well understood.”

    There is a particular risk associated with those living with untreated HIV infections, he added, urging countries to keep testing capacity and be ready to respond promptly if cases rise again.

    “Integration of mpox prevention and care into existing health programmes is recommended, to allow continued access to care, and rapid response to address future outbreaks.”

    WHO will continue to work towards supporting access to countermeasures as more information on effectiveness of interventions becomes available.

    “While the emergencies of mpox and COVID-19 are both over, the threat of resurgent waves remain for both,” Ghebreyesus said.

    “Both viruses continue to circulate, and both continue to kill.

    And while two public health emergencies have ended in the past week, every day WHO continue to respond to more than 50 emergencies globally.”

    Ghebreyesus said that as the UN approached the upcoming World Health Assembly and three-level meetings on pandemic preparedness, tuberculosis and universal health coverage, there were many challenges ahead, but also unprecedented opportunities.

    “If real commitments can be made, then real benefits could result, “for generations to come.”

    Each meeting will be an opportunity to catalyse political commitment to drive progress, and to generate concrete action and financial resources.

    “To invest in expanding access to prevention, testing, treatment, vaccines and research for TB.

    “To strengthen the world’s defences against pandemics; and to strengthen health systems, especially primary healthcare, so that no one misses out on the care they need because of who they are, where they live or how much they earn,”   Ghebreyesus said.

  • WHO renames Monkeypox virus over stigma

    WHO renames Monkeypox virus over stigma

    The World Health Organisation (WHO), has decided to use the name Mpox for a virus previously known as Monkeypox, the body announced in Geneva on Monday.

    TheNewsGuru.com (TNG) reports this is coming in the wake of reports of racist and stigmatising language surrounding the name of the disease.

    The decision follows a series of consultations with global experts.

    Both terms will be used simultaneously for a year before the monkeypox name is phased out.

    “This serves to mitigate the concerns raised by experts about confusion caused by a name change in the midst of a global outbreak,” the UN health agency said in a statement.

    Mpox is a rare viral disease that primarily occurs in tropical rainforest areas of Central and West Africa, but outbreaks emerged in other parts of the world this year.

    There have more than 80,000 cases, and 55 deaths, with 110 countries affected.

    When the current outbreak expanded, WHO both observed and received reports of racist and stigmatising language online, in other settings and in some communities.

    “In several meetings, public and private, a number of individuals and countries raised concerns and asked WHO to propose a way forward to change the name,” the agency said.

    The monkeypox name was given in 1970, some 12 years after the virus that causes the disease was discovered in captive monkeys.

    This was before WHO first published best practices on naming diseases in 2015.

    These guidelines recommend that new disease names should aim to minimise unnecessary negative impacts on trade, travel, tourism or animal welfare.

    They should also avoid offending any cultural, social, national, regional, professional or ethnic groups.

    WHO assigns names to new and, very exceptionally, existing diseases, through a consultative process.

    Medical and scientific experts, representatives from government authorities from 45 countries, as well as the general public, were invited to submit their suggestions.

    Based on the consultations, and further discussions with WHO Director-General Tedros Ghebreyesus, the agency has recommended adoption of the mpox synonym.

    Considerations included rationale, scientific appropriateness, extent of current usage, pronounceability, usability in different languages, absence of geographical or zoological references, and the ease of retrieval of historical scientific information.

    WHO will adopt the term mpox in its communications, and encourages others to follow suit.

    The NewasAgency of Nigeria reports that the disease was called monkey pox because it was first discovered in monkeys in 1958.

    However, monkeys had nothing to do with the outbreaks this year. Rather, humans became infected through close physical contact with other humans.

    Nevertheless, monkeys were attacked this year in Brazil, for example, because humans held them responsible for the outbreaks.

    According to WHO guidelines, disease names should avoid references to specific countries, regions or animals.

    In addition, the name should be easy to pronounce.